Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOBENGUANE I-131 vs IODIXANOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IOBENGUANE I-131 vs IODIXANOL: Safety Overview

Metric IOBENGUANE I-131 IODIXANOL
Total FAERS Reports 123 2,068
Deaths Reported 13 140
Death Rate 10.6% 6.8%
Hospitalizations 25 740
Average Patient Age 22.3 yrs 61.5 yrs
% Female Patients 50.0% 49.4%
FDA Approval Date Jul 30, 2018 Aug 29, 1997
Manufacturer N/A FRESENIUS KABI USA, LLC
Route N/A INTRAVASCULAR
Marketing Status Discontinued Prescription